vimarsana.com

Page 88 - ஸ்கிரிப்ட்கள் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Molecular breakthrough? NCSU scientists advance biosynthetic assembly line technology

by Tracey Peake April 14, 2021 . RALEIGH – Bacteria – such as E. coli – harness biosynthesis to create molecules that are difficult to make artificially. “We already use bacteria to make a number of drugs for us,” says Edward Kalkreuter, former graduate student at NC State and lead author of a paper describing the research. “But we also want to make alterations to these compounds; for example, there’s a lot of drug resistance to erythromycin. Being able to make molecules with similar activity but improved efficacy against resistance is the general goal.” Picture an automobile assembly line: each stop along the line features a robot that chooses a particular piece of the car and adds it to the whole. Now substitute erythromycin for the car, and an acyltransferase (AT) – an enzyme – as the robot at the stations along the assembly line. Each AT “robot” will select a chemical block, or extender unit, to add to the molecule. At each station the AT robot has

Researchers Streamline Molecular Assembly Line to Design, Test Drug Compounds

Date Time Researchers Streamline Molecular Assembly Line to Design, Test Drug Compounds Researchers from North Carolina State University have found a way to fine-tune the molecular assembly line that creates antibiotics via engineered biosynthesis. The work could allow scientists to improve existing antibiotics as well as design new drug candidates quickly and efficiently. Bacteria – such as E. coli – harness biosynthesis to create molecules that are difficult to make artificially. “We already use bacteria to make a number of drugs for us,” says Edward Kalkreuter, former graduate student at NC State and lead author of a paper describing the research. “But we also want to make alterations to these compounds; for example, there’s a lot of drug resistance to erythromycin. Being able to make molecules with similar activity but improved efficacy against resistance is the general goal.”

Researchers streamline molecular assembly line to design, test drug compounds

Researchers streamline molecular assembly line to design, test drug compounds
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

HIV: Clinical trial brings vaccine one step closer

In addition, access to prevention and treatment services is limited in some parts of the world. The World Health Organization (WHO) estimates that, as a result, there were 1.7 million new infections with HIV in 2019, and 690,000 people died from HIV-related causes. Despite decades of work, scientists have failed to develop an effective vaccine against the virus. The reason for this is that most of the surface of the virus is densely coated with sugar molecules that do not trigger an immune response, and the parts that are exposed are highly variable. As with SARS-CoV-2, which is the virus that causes COVID-19, HIV uses spike proteins on its outer surface to gain entry to its host cells.

10 April 2021 Coronavirus Charts and News: Are We Doing The Right Thing In Vaccinating And Then Vaccinating Again For Variants ad Infinitum?

10 April 2021 Coronavirus Charts and News: Are We Doing The Right Thing In Vaccinating And Then Vaccinating Again For Variants ad Infinitum?
econintersect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econintersect.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.